Invention Grant
- Patent Title: Heparinases obtained from Sphingobacterium daejeonense, preparation therefor and application thereof
-
Application No.: US15555040Application Date: 2015-05-25
-
Publication No.: US10214735B2Publication Date: 2019-02-26
- Inventor: Jiake Bai
- Applicant: SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.
- Applicant Address: CN Guangdong
- Assignee: Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Current Assignee: Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Current Assignee Address: CN Guangdong
- Agency: Sanberg Phoenix & von Gontard PC
- Priority: CN201410839278 20150305
- International Application: PCT/CN2015/079704 WO 20150525
- International Announcement: WO2016/138700 WO 20160909
- Main IPC: C12R1/01
- IPC: C12R1/01 ; C12Q1/527 ; C12N9/88

Abstract:
Isolated and prepared heparinases SDhep I and SDhep II obtained from a bacterium Sphingobacterium daejeonense are heparin enzymes that have not been reported. The isolated and prepared enzymes were obtained by steps of bacterium fermentation, crude enzyme extraction, multi-step column chromatography and so on. A study in properties showed that the two enzymes are specific for enzymolysis of heparin and are expected to be used in low molecular weight heparins preparation or heparin quality testing.
Public/Granted literature
- US20180051270A1 HEPARINASES OBTAINED FROM SPHINGOBACTERIUM DAEJEONENSE, PREPARATION THEREFOR AND APPLICATION THEREOF Public/Granted day:2018-02-22
Information query